ACTIVE SUBSTANCE / INN

INSULIN DEGLUDEC;LIRAGLUTIDE

Brand name(s): Xultophy
EMA LISTED
AUTHORISED
Diabetes Mellitus, Type 2
ACTIVE SUBSTANCE
Insulin Degludec;Liraglutide
REGULATORS
EMA
SPONSORS / MAH
Novo Nordisk A/S
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
XultophyNovo Nordisk A/SAuthorised18/09/2014Diabetes Mellitus, Type 2

FULL INTELLIGENCE ON INSULIN DEGLUDEC;LIRAGLUTIDE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →